Spinal cord injury (SCI) has considerable impact on patient physical, mental, and financial
health. Secondary SCI is associated with inflammation, vascular destruction, and …

With technological advances in basic research, the intricate mechanism of secondary
delayed spinal cord injury (SCI) continues to unravel at a rapid pace. However, despite our …

Spinal cord injury (SCI) constitutes an inestimable public health issue. The most crucial
phase in the pathophysiological process of SCI concerns the well-known secondary injury …

Simple Summary Mesenchymal stem cells (MSCs) are a promising option for developing
new treatments for spinal cord injury (SCI). They can help repair damaged tissue, making …

Nearly 1.5 million people in the US live with a spinal cord injury (SCI). The cost to the
healthcare system is estimated at over $10 billion annually likely because over 65% of SCIs …

Spinal cord injury (SCI) remains an important public health problem which often causes
permanent loss of muscle strength, sensation, and function below the site of the injury …

Spinal cord injury (SCI) often leads to severe motor, sensory, and autonomic dysfunction in
patients and imposes a huge economic cost to individuals and society. Due to its …

Spinal Cord Injury (SCI), as a devastating and life-altering neurological disorder, is one of
the most serious health issues. Currently, the management of acute SCI includes …

Spinal cord injury (SCI) is a catastrophic condition with high morbidity and mortality that still
lacks effective therapeutic strategies. It is well known that the most important stage in SCI …

Cell-based technologies are used as a therapeutic strategy in spinal cord injury (SCI).
Mesenchymal stem cells (MSCs), which secrete various neurotrophic factors and cytokines …